Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9355 |
High Similarity |
NPD3027 |
Phase 3 |
0.8968 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8889 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8837 |
High Similarity |
NPD1613 |
Approved |
0.8837 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.874 |
High Similarity |
NPD3018 |
Phase 2 |
0.8729 |
High Similarity |
NPD228 |
Approved |
0.8571 |
High Similarity |
NPD2982 |
Phase 2 |
0.8571 |
High Similarity |
NPD2983 |
Phase 2 |
0.8492 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8387 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8281 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8279 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8268 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8244 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.812 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8082 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8045 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8043 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.8014 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8 |
Intermediate Similarity |
NPD4749 |
Approved |
0.8 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7973 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7971 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7951 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7951 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7881 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7846 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7838 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD1511 |
Approved |
0.782 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD940 |
Approved |
0.7815 |
Intermediate Similarity |
NPD846 |
Approved |
0.7761 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7737 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7737 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7734 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7721 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7721 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7708 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7664 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7661 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7632 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7615 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7613 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7613 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7609 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7581 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7576 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7569 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD3060 |
Approved |
0.755 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7533 |
Intermediate Similarity |
NPD37 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7517 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD4678 |
Approved |
0.75 |
Intermediate Similarity |
NPD290 |
Approved |
0.75 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7484 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7464 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7464 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7458 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7458 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7458 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7451 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7448 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7447 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7444 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7431 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7421 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7421 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7413 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7405 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7395 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7395 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7386 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7386 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7357 |
Intermediate Similarity |
NPD943 |
Approved |
0.7355 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7344 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7343 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7343 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7342 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7325 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.731 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7305 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7299 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7297 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7296 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7293 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7285 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.728 |
Intermediate Similarity |
NPD968 |
Approved |
0.7279 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7241 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.723 |
Intermediate Similarity |
NPD6799 |
Approved |
0.723 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7214 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7214 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7214 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7214 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7195 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7181 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7178 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7176 |
Intermediate Similarity |
NPD709 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7164 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7164 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7133 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7132 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7132 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7123 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD844 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.708 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.708 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7037 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7037 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7032 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7027 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD5297 |
Approved |
0.6987 |
Remote Similarity |
NPD2560 |
Approved |
0.6987 |
Remote Similarity |
NPD2563 |
Approved |
0.6986 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6985 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6985 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6978 |
Remote Similarity |
NPD3053 |
Approved |
0.6978 |
Remote Similarity |
NPD2797 |
Approved |
0.6978
|
Remote Similarity |
NPD3055 |
Approved |